PD63 - PD63: Prostate Cancer: Localized: Surgical Therapy V

Podium Presenter(s)

• 

  Ahmed Sayed Ahmed, MD,MSc

  Clinical Fellow
  University of Montreal Health Center, Montreal Quebec, Canada

  PDF Slides and Audio
• FE

  Farouk Elkhatib, BS
• 

  Axel Heidenreich, MD

  Director and Chairman
  University of Cologne
• 

  Andrew Hung, MD

  University of Southern California

  PDF Slides and Audio
• PJ

  Patricia John
• AK

  Amar Kishan, MD

  Assistant Professor
  UCLA
• 

  Brian Lane, MD, PhD

  Spectrum Health

  PDF Slides and Audio
• 

  Matthew Parry

  London School of Hygiene and Tropical Medicine

  PDF Slides and Audio
• FP

  Francesco Porpiglia, MD

  Full Professor of Urology
  University of Turin

  PDF Slides and Audio
• 

  Lucas Regis Placido, MD

  Universitat Autònoma de Barcelona

  PDF Slides
• CR

  Chanan Reitblat

  PDF Slides
• LS

  Lara Franziska Stolzenbach

Presentations:

• 7:00 AM – 9:00 AM

  PD63-01: Radical prostatectomy for patients with high-risk, very-high risk, or metastatic prostate cancer: oncologic results from the MUSIC statewide collaborative
  Brian Robert Lane, MD, PhD – Spectrum Health Medical Group - Urology
• 7:00 AM – 9:00 AM

  PD63-02: Reliability of modern imaging studies for detection and final pathohistological stage in men undergoing radical salvage prostatectomy (RSP) for radiorecurrent prostate cancer (rPC)
  Axel Heidenreich, MD
• 7:00 AM – 9:00 AM

  PD63-03: Treatment Intensification and Outcome in High-Risk Prostate Cancer:A Multi-Institutional Consortium Analysis
  Amar U. Kishan, MD
• 7:00 AM – 9:00 AM

  PD63-04: Detectable Prostate-specific antigen value between 0.01 - 0.1ng/ml following robotic-assisted radical prostatectomy (RARP): Does it correlate with future biochemical recurrence?
  Ahmed Sayed Zakaria Ahmed, MD,MSc
• 7:00 AM – 9:00 AM

  PD63-05: Emulating a Clinical Trial of Radical Prostatectomy versus External Beam Radiation Therapy for High-Grade, Clinically Localized Prostate Cancer
  Chanan Reitblat
• 7:00 AM – 9:00 AM

  PD63-06: MRI confirms different position of the vesicourethral anastomosis after rhabdosphincter reconstruction in robotic prostatectomy: cohort analyses from a Randomized Controlled Trial
  Lucas Regis Placido, MD – Hospital Vall D Hebron
• 7:00 AM – 9:00 AM

  PD63-07: Patient-reported urinary incontinence following radical prostatectomy for prostate cancer and its association with undergoing incontinence surgery: a national population-based study.
  Matthew Parry
• 7:00 AM – 9:00 AM

  PD63-08: Multi-institutional study: Automated performance metrics to predict continence recovery after robotic radical prostatectomy utilizing machine learning
  Andrew Hung, MD
• 7:00 AM – 9:00 AM

  PD63-09: Oncological outcome of localized, lymph node-positive prostate carcinoma after radical prostatectomy
  Lara Franziska Stolzenbach
• 7:00 AM – 9:00 AM

  PD63-10: Orgasmic dysfunction after robot-assisted radical prostatectomy: a survey of patient and partner outcomes
  Farouk Elkhatib, BS
• 7:00 AM – 9:00 AM

  PD63-11: Radical Salvage Prostatectomy (RSP) for Radiorecurrent Prostate Cancer (rPCA): onological and functional outcome of a large contemporary series
  Patricia John
• 7:00 AM – 9:00 AM

  PD63-12: EXTRACAPSULAR EXTENSION ON NEUROVASCULAR BUNDLES DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY PRECISELY LOCALIZED BY 3D AUTOMATIC AUGMENTED-REALITY RENDERING
  Francesco Porpiglia, MD